Previous Article | Next Article 
Clinical Microbiology Reviews, October 2002, p. 680-715, Vol. 15, No. 4
0893-8512/02/$04.00+0 DOI: 10.1128/CMR.15.4.680-715.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Diagnosis and Management of Human Cytomegalovirus Infection in the Mother, Fetus, and Newborn Infant
Maria Grazia Revello and Giuseppe Gerna*
Servizio di Virologia, IRCCS Policlinico San Matteo, 27100 Pavia, Italy
Human cytomegalovirus (HCMV) is the leading cause of congenital viral infection and mental retardation. HCMV infection, while causing asymptomatic infections in most immunocompetent subjects, can be transmitted during pregnancy from the mother with primary (and also recurrent) infection to the fetus. Hence, careful diagnosis of primary infection is required in the pregnant woman based on the most sensitive serologic assays (immunoglobulin M [IgM] and IgG avidity assays) and conventional virologic and molecular procedures for virus detection in blood. Maternal prognostic markers of fetal infection are still under investigation. If primary infection is diagnosed in a timely manner, prenatal diagnosis can be offered, including the search for virus and virus components in fetal blood and amniotic fluid, with fetal prognostic markers of HCMV disease still to be defined. However, the final step for definite diagnosis of congenital HCMV infection is detection of virus in the blood or urine in the first 1 to 2 weeks of life. To date, treatment of congenital infection with antiviral drugs is only palliative both prior to and after birth, whereas the only efficacious preventive measure seems to be the development of a safe and immunogenic vaccine, including recombinant, subunit, DNA, and peptide-based vaccines now under investigation. The following controversial issues are discussed in the light of the most recent advances in the field: the actual perception of the problem; universal serologic screening before pregnancy; the impact of correct counseling on decision making by the couple involved; the role of prenatal diagnosis in ascertaining transmission of virus to the fetus; the impact of preconceptional and periconceptional infections on the prevalence of congenital infection; and the prevalence of congenitally infected babies born to mothers who were immune prior to pregnancy compared to the number born to mothers undergoing primary infection during pregnancy.
* Corresponding author. Mailing address: Servizio di Virologia, IRCCS Policlinico San Matteo, 27100 Pavia, Italy. Phone: 39 0382 502644/420. Fax: 39 0382 502599. E-mail:
g.gerna{at}smatteo.pv.it.
Clinical Microbiology Reviews, October 2002, p. 680-715, Vol. 15, No. 4
0893-8512/02/$04.00+0 DOI: 10.1128/CMR.15.4.680-715.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Lagrou, K., Bodeus, M., Van Ranst, M., Goubau, P.
(2009). Evaluation of the New Architect Cytomegalovirus Immunoglobulin M (IgM), IgG, and IgG Avidity Assays. J. Clin. Microbiol.
47: 1695-1699
[Abstract]
[Full Text]
-
Goegebuer, T., Van Meensel, B., Beuselinck, K., Cossey, V., Van Ranst, M., Hanssens, M., Lagrou, K.
(2009). Clinical Predictive Value of Real-Time PCR Quantification of Human Cytomegalovirus DNA in Amniotic Fluid Samples. J. Clin. Microbiol.
47: 660-665
[Abstract]
[Full Text]
-
Ducroux, A., Cherid, S., Benachi, A., Ville, Y., Leruez-Ville, M.
(2008). Evaluation of New Commercial Real-Time PCR Quantification Assay for Prenatal Diagnosis of Cytomegalovirus Congenital Infection. J. Clin. Microbiol.
46: 2078-2080
[Abstract]
[Full Text]
-
Gerna, G., Sarasini, A., Patrone, M., Percivalle, E., Fiorina, L., Campanini, G., Gallina, A., Baldanti, F., Revello, M. G.
(2008). Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection. J. Gen. Virol.
89: 853-865
[Abstract]
[Full Text]
-
Vauloup-Fellous, C., Ducroux, A., Couloigner, V., Marlin, S., Picone, O., Galimand, J., Loundon, N., Denoyelle, F., Grangeot-Keros, L., Leruez-Ville, M.
(2007). Evaluation of Cytomegalovirus (CMV) DNA Quantification in Dried Blood Spots: Retrospective Study of CMV Congenital Infection. J. Clin. Microbiol.
45: 3804-3806
[Abstract]
[Full Text]
-
Saffert, R. T., Kalejta, R. F.
(2007). Human Cytomegalovirus Gene Expression Is Silenced by Daxx-Mediated Intrinsic Immune Defense in Model Latent Infections Established In Vitro. J. Virol.
81: 9109-9120
[Abstract]
[Full Text]
-
Nozawa, N., Koyano, S., Yamamoto, Y., Inami, Y., Kurane, I., Inoue, N.
(2007). Real-Time PCR Assay Using Specimens on Filter Disks as a Template for Detection of Cytomegalovirus in Urine. J. Clin. Microbiol.
45: 1305-1307
[Abstract]
[Full Text]
-
Albano, M. S., Taylor, P., Pass, R. F., Scaradavou, A., Ciubotariu, R., Carrier, C., Dobrila, L., Rubinstein, P., Stevens, C. E.
(2006). Umbilical cord blood transplantation and cytomegalovirus: posttransplantation infection and donor screening. Blood
108: 4275-4282
[Abstract]
[Full Text]
-
Shimamura, M., Mach, M., Britt, W. J.
(2006). Human Cytomegalovirus Infection Elicits a Glycoprotein M (gM)/gN-Specific Virus-Neutralizing Antibody Response. J. Virol.
80: 4591-4600
[Abstract]
[Full Text]
-
Saffert, R. T., Kalejta, R. F.
(2006). Inactivating a Cellular Intrinsic Immune Defense Mediated by Daxx Is the Mechanism through Which the Human Cytomegalovirus pp71 Protein Stimulates Viral Immediate-Early Gene Expression.. J. Virol.
80: 3863-3871
[Abstract]
[Full Text]
-
Lanari, M., Lazzarotto, T., Venturi, V., Papa, I., Gabrielli, L., Guerra, B., Landini, M. P., Faldella, G.
(2006). Neonatal Cytomegalovirus Blood Load and Risk of Sequelae in Symptomatic and Asymptomatic Congenitally Infected Newborns. Pediatrics
117: e76-e83
[Abstract]
[Full Text]
-
Munro, S. C., Hall, B., Whybin, L. R., Leader, L., Robertson, P., Maine, G. T., Rawlinson, W. D.
(2005). Diagnosis of and Screening for Cytomegalovirus Infection in Pregnant Women. J. Clin. Microbiol.
43: 4713-4718
[Abstract]
[Full Text]
-
Picone, O., Costa, J.-M., Chaix, M.-L., Ville, Y., Rouzioux, C., Leruez-Ville, M.
(2005). Human Cytomegalovirus UL144 Gene Polymorphisms in Congenital Infections. J. Clin. Microbiol.
43: 25-29
[Abstract]
[Full Text]
-
Revello, M. G., Gorini, G., Gerna, G.
(2004). Clinical Evaluation of a Chemiluminescence Immunoassay for Determination of Immunoglobulin G Avidity to Human Cytomegalovirus. CVI
11: 801-805
[Abstract]
[Full Text]
-
Pannuti, C. S., Morello, R. J., de Moraes, J. C., Curti, S. P., Afonso, A. M. S., Camargo, M. C. C., de Souza, V. A. U. F.
(2004). Identification of Primary and Secondary Measles Vaccine Failures by Measurement of Immunoglobulin G Avidity in Measles Cases during the 1997 Sao Paulo Epidemic. CVI
11: 119-122
[Abstract]
[Full Text]
-
Gerna, G., Baldanti, F., Percivalle, E., Zavattoni, M., Campanini, G., Revello, M. G.
(2003). Early Identification of Human Cytomegalovirus Strains by the Shell Vial Assay Is Prevented by a Novel Amino Acid Substitution in UL123 IE1 Gene Product. J. Clin. Microbiol.
41: 4494-4495
[Full Text]
-
Revello, M. G., Lilleri, D., Zavattoni, M., Furione, M., Middeldorp, J., Gerna, G.
(2003). Prenatal Diagnosis of Congenital Human Cytomegalovirus Infection in Amniotic Fluid by Nucleic Acid Sequence-Based Amplification Assay. J. Clin. Microbiol.
41: 1772-1774
[Abstract]
[Full Text]